Fusion PharmaceuticalsI Stock Forecast - 20 Period Moving Average

FUSN Stock  USD 21.32  0.02  0.09%   
The 20 Period Moving Average forecasted value of Fusion PharmaceuticalsInc on the next trading day is expected to be 15.04 with a mean absolute deviation of  2.79  and the sum of the absolute errors of 117.27. Fusion Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Fusion PharmaceuticalsI stock prices and determine the direction of Fusion PharmaceuticalsInc's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Fusion PharmaceuticalsI's historical fundamentals, such as revenue growth or operating cash flow patterns. Although Fusion PharmaceuticalsI's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Fusion PharmaceuticalsI's systematic risk associated with finding meaningful patterns of Fusion PharmaceuticalsI fundamentals over time.
Check out Historical Fundamental Analysis of Fusion PharmaceuticalsI to cross-verify your projections.
  
As of the 29th of March 2024, Fixed Asset Turnover is likely to grow to 0.14, though Inventory Turnover is likely to grow to (6.52). . As of the 29th of March 2024, Common Stock Shares Outstanding is likely to drop to about 36.6 M. In addition to that, Net Loss is likely to grow to about (74.9 M).

Open Interest Against 2024-04-19 Fusion Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Fusion PharmaceuticalsI's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Fusion PharmaceuticalsI's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Fusion PharmaceuticalsI stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Fusion PharmaceuticalsI's open interest, investors have to compare it to Fusion PharmaceuticalsI's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Fusion PharmaceuticalsI is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Fusion. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Fusion PharmaceuticalsI cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Fusion PharmaceuticalsI's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Fusion PharmaceuticalsI's price structures and extracts relationships that further increase the generated results' accuracy.
A commonly used 20-period moving average forecast model for Fusion PharmaceuticalsInc is based on a synthetically constructed Fusion PharmaceuticalsIdaily price series in which the value for a trading day is replaced by the mean of that value and the values for 20 of preceding and succeeding time periods. This model is best suited for price series data that changes over time.

Fusion PharmaceuticalsI 20 Period Moving Average Price Forecast For the 30th of March

Given 90 days horizon, the 20 Period Moving Average forecasted value of Fusion PharmaceuticalsInc on the next trading day is expected to be 15.04 with a mean absolute deviation of 2.79, mean absolute percentage error of 17.03, and the sum of the absolute errors of 117.27.
Please note that although there have been many attempts to predict Fusion Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Fusion PharmaceuticalsI's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Fusion PharmaceuticalsI Stock Forecast Pattern

Backtest Fusion PharmaceuticalsIFusion PharmaceuticalsI Price PredictionBuy or Sell Advice 

Fusion PharmaceuticalsI Forecasted Value

In the context of forecasting Fusion PharmaceuticalsI's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Fusion PharmaceuticalsI's downside and upside margins for the forecasting period are 1.71 and 28.36, respectively. We have considered Fusion PharmaceuticalsI's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
21.32
15.04
Expected Value
28.36
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the 20 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Fusion PharmaceuticalsI stock data series using in forecasting. Note that when a statistical model is used to represent Fusion PharmaceuticalsI stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria86.0258
BiasArithmetic mean of the errors -1.9261
MADMean absolute deviation2.792
MAPEMean absolute percentage error0.1753
SAESum of the absolute errors117.265
The eieght-period moving average method has an advantage over other forecasting models in that it does smooth out peaks and valleys in a set of daily observations. Fusion PharmaceuticalsInc 20-period moving average forecast can only be used reliably to predict one or two periods into the future.

Predictive Modules for Fusion PharmaceuticalsI

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Fusion PharmaceuticalsInc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Fusion PharmaceuticalsI's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
8.0021.3234.64
Details
Intrinsic
Valuation
LowRealHigh
5.6518.9732.29
Details
Bollinger
Band Projection (param)
LowMiddleHigh
4.0814.2024.31
Details
12 Analysts
Consensus
LowTargetHigh
11.9213.1014.54
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Fusion PharmaceuticalsI. Your research has to be compared to or analyzed against Fusion PharmaceuticalsI's peers to derive any actionable benefits. When done correctly, Fusion PharmaceuticalsI's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Fusion PharmaceuticalsInc.

Other Forecasting Options for Fusion PharmaceuticalsI

For every potential investor in Fusion, whether a beginner or expert, Fusion PharmaceuticalsI's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Fusion Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Fusion. Basic forecasting techniques help filter out the noise by identifying Fusion PharmaceuticalsI's price trends.

Fusion PharmaceuticalsI Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Fusion PharmaceuticalsI stock to make a market-neutral strategy. Peer analysis of Fusion PharmaceuticalsI could also be used in its relative valuation, which is a method of valuing Fusion PharmaceuticalsI by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Fusion PharmaceuticalsInc Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Fusion PharmaceuticalsI's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Fusion PharmaceuticalsI's current price.

Fusion PharmaceuticalsI Market Strength Events

Market strength indicators help investors to evaluate how Fusion PharmaceuticalsI stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Fusion PharmaceuticalsI shares will generate the highest return on investment. By undertsting and applying Fusion PharmaceuticalsI stock market strength indicators, traders can identify Fusion PharmaceuticalsInc entry and exit signals to maximize returns.

Fusion PharmaceuticalsI Risk Indicators

The analysis of Fusion PharmaceuticalsI's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Fusion PharmaceuticalsI's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting fusion stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Fusion PharmaceuticalsInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fusion PharmaceuticalsI's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fusion Pharmaceuticalsinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fusion Pharmaceuticalsinc Stock:
Check out Historical Fundamental Analysis of Fusion PharmaceuticalsI to cross-verify your projections.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Fusion Stock analysis

When running Fusion PharmaceuticalsI's price analysis, check to measure Fusion PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fusion PharmaceuticalsI is operating at the current time. Most of Fusion PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Fusion PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fusion PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Fusion PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
CEOs Directory
Screen CEOs from public companies around the world
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Is Fusion PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fusion PharmaceuticalsI. If investors know Fusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fusion PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.45)
Revenue Per Share
0.032
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.25)
Return On Equity
(0.49)
The market value of Fusion PharmaceuticalsInc is measured differently than its book value, which is the value of Fusion that is recorded on the company's balance sheet. Investors also form their own opinion of Fusion PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Fusion PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fusion PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Fusion PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fusion PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fusion PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fusion PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.